[1]
2022. In Silico Studies of Isoflavones as Estrogen Receptor α (ERα) Activators Targeting Cardiovascular Diseases. Journal of Pharmaceutical Negative Results. (Oct. 2022), 1004–1019. DOI:https://doi.org/10.47750/pnr.2022.13.S04.118.